A clinical study of RUCONEST comparison with a competitor product for the treatment of acute attacks of hereditary angioedema
Latest Information Update: 02 Aug 2018
At a glance
- Drugs Conestat alfa (Primary)
- Indications Hereditary angioedema
- Focus Therapeutic Use
- 02 Aug 2018 New trial record
- 25 Jul 2018 According to a media release, patient recruitment in this study is expected to be completed in Q3. The top-line data is expected in Q4 2018.